The Power of Hematopoietic Stem Cell Transplantation (HSCT): A Curative Approach for Diffuse Large B-Cell Lymphoma (DLBCL) Incidentally Detected in a SCID Baby. (PubMed, EJHaem) - Oct 3, 2026 - "Rituximab and low-dose chemotherapy failed to reduce the mass and were complicated by severe infections. The patient subsequently underwent unconditioned haploidentical HSCT with posttransplant cyclophosphamide...Successful HSCT and immune reconstitution may achieve lymphoma control in IL2RG-SCID when conventional chemotherapy is poorly tolerated. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission."
Journal • B Cell Lymphoma • Bone Marrow Transplantation • Diffuse Large B Cell Lymphoma • Genetic Disorders • Hematological Malignancies • Immunology • Infectious Disease • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Primary Immunodeficiency • Transplantation • IL2RG
|
|
Aydan Ikinciogullari; Burcu Sar?gül Cimi; Can Akal; Candan Islamoglu; Emel Unal; Figen Dogu; Gokcan Ozturk; Hasret Erkmen; Is?nsu Kuzu; Seda Kaynak Sahap; Selin Sevinç; Sonay Özdemir; Suat Fitoz; Sule Haskologlu
|